Elliott, which owns a $2.5 billion stake in Phillips 66, had already nominated seven directors to the company's board earlier ...
NEW YORK (Reuters) -Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback